Key facts
- This page summarizes Grant C. Bogle's Form 4 filing for Immuneering Corp (IMRX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 09 Nov 2026, 16:31.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
The option vests and becomes exercisable in equal monthly installments over a three year period commencing on December 9, 2026, and will be fully vested and exercisable on November 9, 2029.